Embecta submits insulin patch pump for FDA clearance
Embecta (Nasdaq:EMBC) announced today that it submitted a 510(k) premarket filing to the FDA for its proprietary insulin patch pump.
Source: massdevice.com
📰 New Jersey Based Embecta News
New Jersey Based Embecta News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from New Jersey Based Embecta. Real-time updates on events, politics, business and more.
Becton Dickinson spins off diabetes biz, enabling Embecta to embark on its own
The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.
Source: medcitynews.com